Article date: May 2017
By: Ana I Caceres, Boyi Liu, Sairam V Jabba, Satyanarayana Achanta, John B Morris, Sven‐Eric Jordt in Volume 174, Issue 9, pages 867-879
Background and Purpose
Eucalyptol (1,8‐cineol), the major ingredient in the essential oil of eucalyptus leaves and other medicinal plants, has long been known for its anti‐inflammatory properties. Eucalyptol interacts with the TRP cation channels among other targets, but it is unclear which of these mediates its anti‐inflammatory effects.
Experimental Approach
Effects of eucalyptol were compared in wild‐type and TRPM8 channel‐deficient mice in two different models: footpad inflammation elicited by complete Freund's adjuvant (CFA) and pulmonary inflammation following administration of LPS. Oedema formation, behavioural inflammatory pain responses, leukocyte infiltration, enzyme activities and cytokine and chemokine levels were measured.
Key Results
In the CFA model, eucalyptol strongly attenuated oedema and mechanical allodynia and reduced levels of inflammatory cytokines (IL‐1β, TNF‐α and IL‐6), effects comparable with those of ibuprofen. In the LPS model of pulmonary inflammation, eucalyptol treatment diminished leukocyte infiltration, myeloperoxidase activity and production of TNF‐α, IL‐1β, IFN‐γ and IL‐6. Genetic deletion of TRPM8 channels abolished the anti‐inflammatory effects of eucalyptol in both models. Eucalyptol was at least sixfold more potent on human, than on mouse TRPM8 channels. A metabolite of eucalyptol, 2‐hydroxy‐1,8‐cineol, also activated human TRPM8 channels.
Conclusion and Implications
Among the pharmacological targets of eucalyptol, TRPM8 channels were essential for its anti‐inflammatory effects in mice. Human TRPM8 channels are more sensitive to eucalyptol than rodent TRPM8 channels explaining the higher potency of eucalyptol in humans. Metabolites of eucalyptol could contribute to its anti‐inflammatory effects. The development of more potent and selective TRPM8 agonists may yield novel anti‐inflammatory agents.
DOI: 10.1111/bph.13760
View this article